Illumina Jumps Most in 15 Months on First-Quarter Profit

Illumina Inc. rose the most in almost 15 months after the maker of genetic decoders reported earnings that exceeded analysts’ estimates on higher sales.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.